1. Volume 143, Issue 2, Pages 390-399.e1 (August 2012)
Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease 
Millie D. Long, Christopher F. Martin, Clare A. Pipkin, Hans H. Herfarth, Robert S. Sandler, Michael D. Kappelman 
Gastroenterology 
Volume 143, Issue 2, Pages e1 (August 2012)
DOI: /j.gastro
Copyright © 2012 AGA Institute Terms and Conditions

2. Figure 1 Incidence of melanoma in IBD and non-IBD populations.
Data from IMS Health, LifeLink Health Plan Claims Database, from 1997 to 2009.
Gastroenterology  , e1DOI: ( /j.gastro )
Copyright © 2012 AGA Institute Terms and Conditions

3. Supplementary Figure 1
Use of biologics by year among patients with IBD, 1997–2009. Biologics defined as infliximab, adalimumab, or certolizumab pegol.
Data from IMS Health, LifeLink Health Plan Claims Database, from 1997 to (NOTE. The first biologic prescription occurred in 1999).
Gastroenterology  , e1DOI: ( /j.gastro )
Copyright © 2012 AGA Institute Terms and Conditions